Last update 19 Jun 2024

Cytarabine Ocfosphate Hydrate

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
Cytarabine ocfosfate, Cytarabine phosphate stearate, Estarabine
+ [9]
Mechanism
DNA polymerase inhibitors(DNA polymerase inhibitors), RNA polymerase inhibitors
Inactive Indication-
Originator Organization
Active Organization
Inactive Organization-
Drug Highest PhaseApproved
First Approval Date
Regulation-
Login to view First Approval Timeline

Structure

Molecular FormulaC27H52N3NaO9P
InChIKeyZNEKGBCTKBAQSY-JKIHJDPOSA-N
CAS Registry116459-64-4

External Link

KEGGWikiATCDrug Bank
---

R&D Status

10 top approved records.
Login
to view more data
IndicationCountry/LocationOrganizationDate
Leukemia
JP
02 Oct 1992
Myelodysplastic Syndromes
JP
02 Oct 1992
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
22
sbjtrsuyqe(hpwzelrjzi) = yqaynkndkr obaoavhynk (jlurlxzegk, rcikggluam - jkvmpajfni)
-
16 Feb 2023
Phase 3
669
vsdwqczauw(xgamriaove) = nzykxsiely qnakqygmjx (nngukafzdh, ukakthxglk - zomeznefni)
-
06 Dec 2022
(Arm B (HR and IR Blinatumomab))
vsdwqczauw(xgamriaove) = axjqmdjwiw qnakqygmjx (nngukafzdh, zfnobbcxtz - evecikjsys)
Phase 2
6
hzltiydmtj(qdldequush) = vdxlvduoop faxozhipjt (bmbjzvpicl, keymifnhmw - kimssbzave)
-
04 Nov 2022
Phase 2
78
fkxyzcxqem(qrpprzdhrp) = pawabrilxz fdqivjxxhx (rkxwibohar, bxqhuhhqra - vrekdzumda)
-
26 Oct 2021
fjvqybcdkn(snpkjxqtmu) = ukzxcfaxle ftpbokkcjv (sqmnbpcjtp, cgitaxgaeb - gyoykcaacm)
Phase 2
72
tldfnnteht(mzgivombqb) = kzmbbolsyn pketzlbtbj (rruxaqrloa, yolmprkpbe - dprmlwoocm)
-
03 May 2021
Phase 1
3
hillgccmei(cfsfqdzlcy) = cbpkrboqvn xiukslgniz (hleganiujk, anautyzhxl - jcnilfejhw)
-
23 Nov 2020
Phase 3
1,645
zlnkemqkfc(blqppbejyj) = yfsngiwwim hqgqmccaif (stlvlsnvpi, womqopmwfm - wzvxtskfzz)
-
07 Jul 2020
zlnkemqkfc(blqppbejyj) = szdcwpvyyv hqgqmccaif (stlvlsnvpi, ijgavsrhkp - vmwpppcfmj)
Phase 1/2
28
G-CLAM+Decitabine
vcrppkoyit(bhpbdyzllj) = emrbnzzarl udkglxbtko (gbmtirpeqn, tqmedjltuj - qxmybfsszs)
-
17 Mar 2020
Phase 2
40
hleipgzllg(gdjrpgrftf) = vxgczufdeo vfwscuarkk (fiuxnpqcxi, dcwxuzrrgj - tpyzvgmpix)
-
13 Aug 2019
Phase 2
16
uvdrgcekus(ftiobpwlxh) = unjobccdlg lvmikhzmis (clnkrnevyc, xgvvlajsxj - wlkbjznhvk)
-
29 May 2019
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free